Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06696118 · ClinicalTrials.gov registry record · NA
Electromagnetic Transduction Therapy on Osteoarthritis in the Foot and Ankle
A NA study of Osteoarthritis Ankle and Osteoarthritis Foot, sponsored by Mayo Clinic.
- Active
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06696118: Active NA study of Osteoarthritis Ankle and Osteoarthritis Foot, sponsored by Mayo Clinic.
NCT06696118 is a NA study of Osteoarthritis Ankle and Osteoarthritis Foot that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 20 participants, below the 6,744-participant average among 3 other Osteoarthritis Ankle trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06696118, a NA study of Osteoarthritis Ankle and Osteoarthritis Foot, is active but no longer recruiting, sponsored by Mayo Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if Electromagnetic Transduction Therapy (EMTT) is a viable treatment option in patients with osteoarthritis of the foot and/or ankle.
Primary Outcome
The VAS is a 11-item questionnaire assessing pain. Using a scale of 0 = no pain to 10 = worst pain. Total scores range from 0 - 110, lower scores indicating lower pain and higher scores indicating greater pain.
Conditions Studied
Interventions
- DEVICE Electromagnetic Transduction Therapy (EMTT)
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-03-13 |
| Est. Completion | 2027-01 |
| Phase | NA |
What the registry record for NCT06696118 still lists
NCT06696118 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 6,744-participant average among 3 other Osteoarthritis Ankle trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Osteoarthritis Ankle appearing as the primary indexed condition, and to 1 intervention - of which Electromagnetic Transduction Therapy (EMTT) is the first listed.
NCT06696118 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT06696118 about?
NCT06696118 is a clinical study titled "Electromagnetic Transduction Therapy on Osteoarthritis in the Foot and Ankle". The purpose of this study is to determine if Electromagnetic Transduction Therapy (EMTT) is a viable treatment option in patients with osteoarthritis of the foot and/or ankle.
What is the current status of trial NCT06696118?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-03-13. Estimated completion is 2027-01.
What conditions does trial NCT06696118 study?
This clinical trial studies the following conditions: Osteoarthritis Ankle, Osteoarthritis Foot.
What interventions are being tested in trial NCT06696118?
The interventions under investigation include: Electromagnetic Transduction Therapy (EMTT) (DEVICE).
Who is sponsoring clinical trial NCT06696118?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06696118 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis Ankle
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI